Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1467526442
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
833 Princeton Ave SW Ste 105a, Pob III
Birmingham, AL, 35211
Phone (205) 786-6983
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
132,258 services
Medicare patients, 2024
232
Average age 73
Drug cost, 2024
$7.4M
3,548 prescriptions
Company payments, 2025
$882
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katisha T Vance was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 35,190 times for 37 patients. In total Katisha T Vance billed 132,258 services in 115 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 35,190 | 37 | $0.28 | $10K |
| J0897 Injection, denosumab, 1 mg | Office | 9,600 | 19 | $19.16 | $184K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 3,065 | 14 | $2.30 | $7,036 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,355 | 28 | $0.09 | $210 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 19 | $16.41 | $31K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 841 | 22 | $0.21 | $179 |
| 85025 Blood Count | Office | 813 | 203 | $7.49 | $6,087 |
| 36415 Venipuncture Blood Collection | Office | 572 | 183 | $8.54 | $4,884 |
| 96367 Intravenous Infusion, Hydration | Office | 450 | 63 | $19.29 | $8,680 |
| J9045 Injection, carboplatin, 50 mg | Office | 267 | 12 | $2.86 | $765 |
| 96413 Chemotherapy Administration | Office | 253 | 38 | $86.03 | $22K |
| 96375 Injection Administration | Office | 232 | 59 | $10.43 | $2,419 |
| 96372 Injection Administration | Office | 220 | 52 | $9.07 | $1,995 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 175 | 51 | $0.63 | $110 |
| 99214 Office E&M - Established | Office | 160 | 90 | $85.69 | $14K |
By year: 2022 $2.0M for 148,119 services; 2023 $1.8M for 133,755 services; 2024 $2.2M for 132,258 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 813 | 203 | $7.49 | $6,087 |
| 36415 Venipuncture Blood Collection | 572 | 183 | $8.54 | $4,884 |
Medicare prescription drug claims, 2024
In 2024, the drug Katisha T Vance prescribed most often to Medicare patients was Anastrozole, with 271 prescriptions and refills. In total Katisha T Vance wrote 3,548 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 271 | 758 | 84 | $6,944 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 245 | 245 | 46 | $7,954 |
| Ondansetron Hcl Generic | 180 | 183 | 62 | $2,450 |
| Prochlorperazine Maleate Generic | 162 | 162 | 104 | $3,301 |
| Dexamethasone Generic | 159 | 161 | 52 | $978 |
| Gabapentin Generic | 121 | 131 | 32 | $1,536 |
| Promethazine Hcl Generic | 95 | 95 | 66 | $1,010 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 88 | 88 | 19 | $2,883 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 81 | 113 | 25 | $479 |
| Morphine Sulfate Er Morphine Sulfate | 75 | 75 | 14 | $2,266 |
| Xarelto Rivaroxaban | 74 | 140 | 23 | $83K |
| Acyclovir Generic | 68 | 102 | 11 | $1,080 |
| Potassium Chloride Generic | 68 | 82 | 26 | $583 |
| Prednisone Generic | 66 | 72 | 19 | $265 |
| Hydrocortisone Generic | 66 | 70 | Under 11 | $1,657 |
Brand drugs: - claims; generic drugs: 2,996 claims; opioid claims: 508.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katisha T Vance $882 ($882 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $100.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $100 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $93.68 |
| Daiichi Sankyo Inc. 4568.T | 4 | $75.28 |
| Sobi, Inc SOBI.ST | 3 | $62 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $59.05 |
| Abbvie Inc. ABBV | 3 | $55.51 |
| Geron Corporation GERN | 2 | $51.88 |
| BeOne Medicines USA, Inc. ONC | 2 | $36.05 |
| Fennec Pharmaceuticals, Inc. FENC | 2 | $35.01 |
| Stemline Therapeutics Inc. | 1 | $27.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.